← Back to the catalogue
Glycoproteins
GlycB
NMR signal of β/γ acute-phase glycoproteins (mainly transferrin and immunoglobulin G), complementary to GlycA and related to the adaptive immune response.
Application contexts
- Inflammation and immunity
Matrices
- Serum or plasma
Related techniques
- ¹H-NMR
Related publications
- Characterization of 1H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid Arthritis. 2018 · Journal of proteome research · 73 citations
- Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study. 2020 · Journal of clinical medicine · 22 citations
- Glycoprotein Profile Measured by a 1H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation. 2021 · Life (Basel, Switzerland) · 21 citations
Show 8 more Show less
- Acute-phase glycoprotein profile responses to different oral macronutrient challenges: Influence of sex, functional hyperandrogenism and obesity. 2021 · Clinical nutrition (Edinburgh, Scotland) · 17 citations
- Serum glycoproteins A and B assessed by 1H-NMR in familial hypercholesterolemia. 2021 · Atherosclerosis · 15 citations
- GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. 2022 · The American journal of cardiology · 12 citations
- Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes. 2022 · Diabetes care · 8 citations
- Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. 2025 · Cardiovascular diabetology · 5 citations
- Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers. 2021 · Frontiers in immunology · 5 citations
- Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. 2025 · Revista espanola de enfermedades digestivas
- Glycoprotein Determination with NMR Spectroscopy to Evaluate the Effect of Metabolic Surgery over the Proinflammatory State of Patients with Obesity. 2025 · Obesity surgery
Related news
- Icosapent ethyl and residual cardiovascular risk: what NMR reveals beyond triglycerides 16 September 2026 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Low-Grade Inflammation and Glycoproteins: New Evidence After Metabolic Surgery 17 November 2025 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Liposcale and Glycoscale in Cardiovascular Risk Prediction in Type 2 Diabetes 25 March 2025 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
Show 17 more Show less
- Metabolomics in Sports: Applications in Performance and Recovery 24 October 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Nutrition and Cardiovascular Health: Reflections on World Food Day 16 October 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Familial Hypercholesterolemia and the Importance of Metabolomics for Its Detection and Personalized Treatment 24 September 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Role of Metabolomics in Infectious Diseases: A Cross-sectional Approach 19 September 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Neurodegenerative Diseases: Metabolomics to Reveal Biomarkers for Early Diagnosis 11 April 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Understanding the Impact of Bariatric Surgery on Dyslipidemia and Cardiovascular Risk Reduction 02 April 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Metabolomics and Sexual Reproductive Health 12 December 2023 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- What does metabolomics contribute to HIV research? 30 November 2023 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Glycoproteins: Emerging Markers of Inflammation 20 November 2023 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- What is metabolomics and how is it applied in diabetes? 13 November 2023 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Biosfer Teslab launches MetBalance Test 04 October 2022 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Our lipoprotein and glycoprotein test in the SEA conference 04 April 2022 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Barça Innovation Hub: Metabolomics at the forefront of elite sport 16 November 2021 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Liposcale for early and reliable diagnosis and prognosis of breast cancer patients 08 September 2021 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- GlycA as a new biomarker in rheumatoid arthritis 21 October 2020 · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
Related projects
- AVANTE 2023 · Consortium coordinator · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- CARDIOSCOPE 2022 · Consortium partner · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
Show 3 more Show less
- VISIONING 2021 · Co-principal investigator, with the IRB CatSud metabolomics platform · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Torres Quevedo · Diagnostic metabolomics 2020 · Beneficiary company · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)
- Industrial Doctoral Plan Fellowship 2016 · Beneficiary company · Panel: NMR glycoproteins (GlycA, GlycB, GlycF)